201 related articles for article (PubMed ID: 37377752)
1. Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring
Ohshima K; Nagashima T; Fujiya K; Hatakeyama K; Watanabe Y; Morimoto K; Kamada F; Shimoda Y; Ohnami S; Naruoka A; Serizawa M; Ohnami S; Kenmotsu H; Shiomi A; Tsubosa Y; Bando E; Sugiura T; Sugino T; Terashima M; Uesaka K; Urakami K; Akiyama Y; Yamaguchi K
Cancer Res Commun; 2023 Apr; 3(4):684-696. PubMed ID: 37377752
[TBL] [Abstract][Full Text] [Related]
2. KIT Exon 11 Codons 557-558 Deletion Mutation Promotes Liver Metastasis Through the CXCL12/CXCR4 Axis in Gastrointestinal Stromal Tumors.
Wang HC; Li TY; Chao YJ; Hou YC; Hsueh YS; Hsu KH; Shan YS
Clin Cancer Res; 2016 Jul; 22(14):3477-87. PubMed ID: 26936919
[TBL] [Abstract][Full Text] [Related]
3. Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors.
Shen YY; Ma XL; Wang M; Zhuang C; Ni B; Tu L; Liu Q; Zhao WY; Cao H
Cancer Med; 2020 Sep; 9(18):6485-6496. PubMed ID: 32697050
[TBL] [Abstract][Full Text] [Related]
4. KIT exon 11 codon 557/558 deletion/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential.
Kontogianni-Katsarou K; Dimitriadis E; Lariou C; Kairi-Vassilatou E; Pandis N; Kondi-Paphiti A
World J Gastroenterol; 2008 Mar; 14(12):1891-7. PubMed ID: 18350628
[TBL] [Abstract][Full Text] [Related]
5. Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11.
Gregory-Bryson E; Bartlett E; Kiupel M; Hayes S; Yuzbasiyan-Gurkan V
BMC Cancer; 2010 Oct; 10():559. PubMed ID: 20950418
[TBL] [Abstract][Full Text] [Related]
6. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O
Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103
[TBL] [Abstract][Full Text] [Related]
7. Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.
Joensuu H; Wardelmann E; Sihto H; Eriksson M; Sundby Hall K; Reichardt A; Hartmann JT; Pink D; Cameron S; Hohenberger P; Al-Batran SE; Schlemmer M; Bauer S; Nilsson B; Kallio R; Junnila J; Vehtari A; Reichardt P
JAMA Oncol; 2017 May; 3(5):602-609. PubMed ID: 28334365
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
[No Abstract] [Full Text] [Related]
9. High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors.
Belinsky MG; Skorobogatko YV; Rink L; Pei J; Cai KQ; Vanderveer LA; Riddell D; Merkel E; Tarn C; Eisenberg BL; von Mehren M; Testa JR; Godwin AK
Genes Chromosomes Cancer; 2009 Oct; 48(10):886-96. PubMed ID: 19585585
[TBL] [Abstract][Full Text] [Related]
10. Increased KIT signalling with up-regulation of cyclin D correlates to accelerated proliferation and shorter disease-free survival in gastrointestinal stromal tumours (GISTs) with KIT exon 11 deletions.
Haller F; Löbke C; Ruschhaupt M; Schulten HJ; Schwager S; Gunawan B; Armbrust T; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
J Pathol; 2008 Oct; 216(2):225-35. PubMed ID: 18729075
[TBL] [Abstract][Full Text] [Related]
11. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ
Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
[TBL] [Abstract][Full Text] [Related]
12. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas.
Lasota J; Jasinski M; Sarlomo-Rikala M; Miettinen M
Am J Pathol; 1999 Jan; 154(1):53-60. PubMed ID: 9916918
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases.
Lasota J; Corless CL; Heinrich MC; Debiec-Rychter M; Sciot R; Wardelmann E; Merkelbach-Bruse S; Schildhaus HU; Steigen SE; Stachura J; Wozniak A; Antonescu C; Daum O; Martin J; Del Muro JG; Miettinen M
Mod Pathol; 2008 Apr; 21(4):476-84. PubMed ID: 18246046
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal aberrations in primary PDGFRA-mutated gastrointestinal stromal tumors.
Schaefer IM; Delfs C; Cameron S; Gunawan B; Agaimy A; Ghadimi BM; Haller F
Hum Pathol; 2014 Jan; 45(1):85-97. PubMed ID: 24157063
[TBL] [Abstract][Full Text] [Related]
15. A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del).
Huss S; Künstlinger H; Wardelmann E; Kleine MA; Binot E; Merkelbach-Bruse S; Rüdiger T; Mittler J; Hartmann W; Büttner R; Schildhaus HU
Mod Pathol; 2013 Jul; 26(7):1004-12. PubMed ID: 23599150
[TBL] [Abstract][Full Text] [Related]
16. [Differences in clinicopathological features, gene mutations, and prognosis between primary gastric and intestinal gastrointestinal stromal tumors in 1061 patients].
Li JX; Sun L; Zhao S; Shao B; Guo YH; Chen S; Liang H; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Apr; 26(4):346-356. PubMed ID: 37072312
[No Abstract] [Full Text] [Related]
17. [c-kit and PDGFRA mutations in 60 cases of gastrointestinal stromal tumors (GISTs)].
He HY; Xiang YN; Li Y; Zhong HH; Wu BQ; Zheng J
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):320-4. PubMed ID: 15968329
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases.
Lasota J; Wozniak A; Kopczynski J; Dansonka-Mieszkowska A; Wasag B; Mitsuhashi T; Sarlomo-Rikala M; Lee JR; Schneider-Stock R; Stachura J; Limon J; Miettinen M
Lab Invest; 2005 Feb; 85(2):237-47. PubMed ID: 15580284
[TBL] [Abstract][Full Text] [Related]
19. Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors.
Lourenço N; Hélias-Rodzewicz Z; Bachet JB; Brahimi-Adouane S; Jardin F; Tran van Nhieu J; Peschaud F; Martin E; Beauchet A; Chibon F; Emile JF
Mol Cancer; 2014 Nov; 13():246. PubMed ID: 25373456
[TBL] [Abstract][Full Text] [Related]
20. KIT exon 11 deletion-inversions represent complex mutations in gastrointestinal stromal tumors.
Lasota J; Miettinen M
Cancer Genet Cytogenet; 2007 May; 175(1):69-72. PubMed ID: 17498562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
